AMP Capital Investors Ltd lessened its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 34.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,085 shares of the medical instruments supplier’s stock after selling 3,700 shares during the quarter. AMP Capital Investors Ltd’s holdings in Merit Medical Systems were worth $363,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Mount Yale Investment Advisors LLC bought a new stake in shares of Merit Medical Systems in the 1st quarter worth about $156,000. Campbell & CO Investment Adviser LLC bought a new stake in shares of Merit Medical Systems in the 2nd quarter worth about $206,000. Intrust Bank NA bought a new stake in shares of Merit Medical Systems in the 2nd quarter worth about $211,000. Envestnet Asset Management Inc. grew its holdings in shares of Merit Medical Systems by 1,336.8% in the 1st quarter. Envestnet Asset Management Inc. now owns 4,842 shares of the medical instruments supplier’s stock worth $221,000 after purchasing an additional 4,505 shares during the last quarter. Finally, SG Americas Securities LLC bought a new stake in shares of Merit Medical Systems in the 1st quarter worth about $237,000. 86.96% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ:MMSI opened at $61.20 on Tuesday. Merit Medical Systems, Inc. has a 12 month low of $36.21 and a 12 month high of $63.20. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.66. The stock has a market cap of $3.36 billion, a price-to-earnings ratio of 47.93, a P/E/G ratio of 2.90 and a beta of 1.33.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Monday, July 23rd. The medical instruments supplier reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.03. Merit Medical Systems had a net margin of 2.44% and a return on equity of 10.48%. The firm had revenue of $224.81 million for the quarter, compared to analyst estimates of $214.64 million. During the same quarter in the prior year, the firm earned $0.36 EPS. The company’s revenue was up 20.5% on a year-over-year basis. analysts expect that Merit Medical Systems, Inc. will post 1.64 earnings per share for the current fiscal year.

Several equities research analysts have recently weighed in on MMSI shares. SunTrust Banks reaffirmed a “buy” rating and issued a $62.00 target price (up previously from $55.00) on shares of Merit Medical Systems in a report on Friday, June 1st. Needham & Company LLC reaffirmed a “buy” rating and issued a $54.00 target price on shares of Merit Medical Systems in a report on Friday, June 1st. Wells Fargo & Co upped their target price on shares of Merit Medical Systems from $53.00 to $58.00 and gave the stock an “outperform” rating in a report on Monday, June 4th. BidaskClub lowered shares of Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a report on Thursday, June 7th. Finally, Zacks Investment Research raised shares of Merit Medical Systems from a “hold” rating to a “buy” rating and set a $57.00 target price on the stock in a report on Tuesday, June 26th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $63.25.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management.

See Also: How is an ETF different from a mutual fund?

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.